As we gain market share and invest in our platform, we expect these new TAMs to drive strong growth and profitability just as we have in our core. And over the long term, we will continue to invest to ...
Joining me on today's call are our CEO, Matthew Desch and our CFO, Vincent J. O'Neill. Today's call will begin with a ...
PALISADE-4 Phase 3 Trial of fasedienol for acute treatment of Social Anxiety Disorder proceeding, with topline results from the randomized portion of the trial expected in the first half of 2026SOUTH ...
ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...
“Codex-Spark is the first step toward a Codex that works in two complementary modes: real-time collaboration when you want ...
Plenty of our childhoods had at least one math teacher who made the (ultimately erroneous) claim that we needed to learn to do math because we wouldn’t always have a calculator in our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results